# Hole-Doping Effect on Superconductivity in Compressed CeH$_{9}$ at High Pressure

Preprint · Chongze Wang, Shuyuan Liu, Hyunsoo Jeon, Seho Yi, Yunkyu Bang, Jun-Hyung Cho

- Archive id: arxiv:2101.03481
- Published: 2021-01-10
- Venue: Phys. Rev. B 104, 020504 (2021)
- DOI: https://doi.org/10.1103/physrevb.104.l020504
- arXiv: https://arxiv.org/abs/2101.03481
- Source URL: https://arxiv.org/abs/2101.03481
- PDF: https://arxiv.org/pdf/2101.03481
- Provenance: arxiv

## Abstract

The experimental realization of high-temperature superconductivity in compressed hydrides H$\_3$S and LaH$\_{10}$ at high pressures over 150 GPa has aroused great interest in reducing the stabilization pressure of superconducting hydrides. For cerium hydride CeH$\_9$ recently synthesized at 80$-$100 GPa, our first-principles calculations reveal that the strongly hybridized electronic states of Ce 4$f$ and H 1$s$ orbitals produce the topologically nontrivial Dirac nodal lines around the Fermi energy $E\_F$, which are protected by crystalline symmetries. By hole doping, $E\_F$ shifts down toward the topology-driven van Hove singularity to significantly increase the density of states, which in turn raises a superconducting transition temperature $T\_c$ from 74 K up to 136 K at 100 GPa. The hole-doping concentration can be controlled by the incorporation of Ce$^{3+}$ ions with varying their percentages, which can be well electronically miscible with Ce atoms in the CeH$\_9$ matrix because both Ce$^{3+}$ and Ce behave similarly as cations. Therefore, the interplay of symmetry, band topology, and hole doping contributes to enhance $T\_c$ in compressed CeH$\_9$. This mechanism to enhance $T\_c$ can also be applicable to another superconducting rare earth hydride LaH$\_{10}$.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.